Introduction
The two main indications of adenosine administration are pharmacological stress myocardial scintigraphy (vasodilatation effect) and supraventricular tachyarrhythmia (SVT) termination known as atrioventricular blocking effect. Both dipyridamole and adenosine vasodilators have been used in pharmacological stress tests.
unremarkable. An electrocardiogram showed narrow complex tachycardia (SVT) with a ventricular rate of 203 beats/min ( fig. 1 ) . A vagal stimulation maneuver was attempted to convert the rhythm but was unsuccessful. Subsequently, a bolus of 6 mg adenosine was administered intravenously with successful conversion to sinus rhythm. Repeat electrocardiography demonstrated normal sinus rhythm with significant ST segment elevation in the inferior leads and reciprocal ST depression in leads I, aVL and V2 ( fig. 2 ). At this point, the patient was still having chest discomfort slightly severer than before. The patient was treated with sublingual 0.5 mg of nitroglycerin, and repeated electrocardiography demonstrated resolution of the ST segment changes ( fig. 3 ) with a marked relief of her symptoms. The patient was subsequently admitted to the Coronary Care Unit and treated with intravenous anticoagulants, antiplatelet agents (aspirin and clopidogrel), isosorbide dinitrates and diltiazem. In laboratory investigations, se- rial troponin T levels were 0.24, 0.35 and 0.28 ng/ml (normal ! 0.01). The remainder of the evaluations were within the normal range. Transthoracic echocardiography revealed hypokinetic segments in the inferolateral areas of the left ventricle with left ventricular ejection fraction of 50%, normal valves and normal pericardium. Coronary angiography was subsequently performed on the second day and demonstrated patent coronary vessels. Subsequently, the patient underwent successful ablation of the slow pathway of the atrioventricular nodal reentrant tachycardia. The patient was eventually discharged home and since the episode has had no recurrences of symptoms.
Discussion
This case demonstrated an unusual complication of intravenous administration of adenosine, coronary artery spasm. Both clinical (chest pain) and electrocardiographic (ST segment elevation) evidence of ischemia were reported immediately after adenosine administration, both of which were reverted by sublingual nitrates in this patient. The normal coronary angiography ruled out an atherosclerotic etiology (plaque rupture) as the cause of the patient's ischemia. Vasospastic etiology of the right coronary artery was the most probable explanation of the transient ST elevation in the inferior leads, which was reverted by the antispastic effect of nitroglycerin.
Adenosine acts on adenosine receptors in the sinoatrial node, the atrioventricular node, the coronary arteries and ventricular myocytes, having a vasodilator effect on the coronary microcirculation and a negative chronotropic action. Adenosine has been used in both indications (pharmacological stress test and SVT) with an excellent safety profile. Though rare, coronary vasospasm has been reported and documented as an adverse effect of the dipyridamole stress test [1] . However, adenosineinduced coronary vasospasm has only recently been reported [2, 3] .
Coronary spasm is thought to be indirectly a result of the abrupt withdrawal of the short-acting vasodilator effect of adenosine [5] . This is added to a predisposition of vulnerable vessels (coronary hypersensitivity). However, the exact mechanism of coronary vasospasm is still unclear [7, 8] . The role of the autonomic nervous system is controversial. Adenosine stimulates baroreceptors by the vasodilator and hypotensive effect, which in turn leads to sympathetic activation and increased plasma catecholamine concentration [9] , and this can trigger the coronary spasm. On the other hand, the endothelium releases both vasodilator and vasoconstrictive factors. The final reaction is thought to be determined by the ultimate balance of action of those factors.
Most of the other reported side effects of adenosine such as flushing, headache, nausea, chest pain or discomfort and shortness of breath are mild and transient in nature [3] . However, more significant adverse effects, which are described more with intravenous adenosine infusion, have been reported rarely. These include cardiac complications such as significant hemodynamic heart block, asystole, hypotension, atrial fibrillation (upon termination of SVT), and more malignant arrhythmias such as torsades de pointes, ventricular tachycardia, ventricular fibrillation and potential cardiac arrest. Significant noncardiac complications include bronchospasm and potential respiratory arrest, dizziness, increased intracranial pressure and seizures [5] . Previously documented cases in the literature report coronary spasm that was induced by intravenous infusion of adenosine during a pharmacological stress test [2] [3] [4] [5] [6] , involving the anterior, lateral and inferior territories. In our case, the spasm was induced by a bolus dose of adenosine (6 mg i.v.) given for SVT termination, and it involved the inferior (right coronary) territory. Other potential causes for chest pain and transient ST segment elevation in this patient are unlikely. First, spontaneous chest pain did not precede the palpitations in this patient but only occurred after adenosine infusion. She has been asymptomatic since ablation therapy, making spontaneous coronary spasm less likely [10, 11] . Second, although vagally mediated coronary spasm has been described in the literature very rarely [11, 12] , almost all of those patients had vagal symptoms prior to the onset of chest pain. On the other hand, the current patient did not have vagal symptoms and in fact the vagal maneuver was unsuccessful in terminating the arrhythmia; moreover, the chest pain and ECG changes only occurred after adenosine infusion.
Conclusion
This report showed a case of coronary spasm secondary to the administration of adenosine. We therefore recommend that discretion be exercised when giving adenosine, especially to patients with an underlying tendency for vasospastic reactions.
